يعرض 1 - 20 نتائج من 23 نتيجة بحث عن '"Campelo, RG"', وقت الاستعلام: 0.42s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Conference

    المساهمون: Christie NHS Foundation Trust and The University of Manchester, Manchester

    Relation: Krebs MG, Brunsvig P, Helland A, Segarra N, Aix S, Costa E, et al. A phase II study of bemcentinib (BGB324), a first-in-class selective AXL inhibitor, in combination with pembrolizumab in patients with advanced NSCLC: Updated analysis. Journal for Immunotherapy of Cancer. 2019;7; http://hdl.handle.net/10541/622634; Journal for Immunotherapy of Cancer

  4. 4
    Conference

    المساهمون: Medical Oncology, Hospital Universitario Virgen de la Victoria, Malaga, Spain

    Relation: https://dx.doi.org/10.1093/annonc/mdz260.098; Trigo Perez JM, Felip E, Brunsvig P, Helland A, Viñolas N, Ponce Aix S, et al. 1576P Efficacy results of selective AXL inhibitor bemcentinib with pembrolizumab following chemo in patients with NSCLC. Annals of Oncology. 2019;30(Supplement_5):649.; http://hdl.handle.net/10541/622594; Annals of Oncology

  5. 5
    Conference

    المساهمون: Manchester Academic Health Sciences Centre, The Christie NHS Foundation Trust and the University of Manchester, Manchester

    Relation: https://dx.doi.org/10.1016/j.jtho.2019.08.787; Krebs M, Brunsvig P, Helland Å, Viñolas N, Aix S, Carcereny E, et al. P1.01-72 A Phase II Study of Selective AXL Inhibitor Bemcentinib and Pembrolizumab in Patients with NSCLC Refractory to Anti-PD(L)1. Journal of Thoracic Oncology. 2019;14(10):S388.; http://hdl.handle.net/10541/622535; Journal of Thoracic Oncology

  6. 6
    Conference

    المساهمون: Vall D'hebron University Hospital, Barcelona

    Relation: https://dx.doi.org/10.1016/j.jtho.2019.08.515; Felip E, Brunsvig P, Helland Å, Viñolas N, Aix S, Carcereny E, et al. MA03.06 Efficacy Results of Selective AXL Inhibitor Bemcentinib with Pembrolizumab Following Chemotherapy in Patients with NSCLC. Journal of Thoracic Oncology. 2019;14(10):S258-S9.; http://hdl.handle.net/10541/622531; Journal of Thoracic Oncology

  7. 7
    Conference

    المساهمون: Hospital Universitari Vall d'Hebron, Barcelona, Spain

    Relation: https://dx.doi.org/10.1200/JCO.2019.37.15_suppl.9098; Felip E, Brunsvig P, Vinolas N, Aix S, Costa E, Gomez M, et al. A phase II study of bemcentinib (BGB324), a first-in-class highly selective AXL inhibitor, with pembrolizumab in pts with advanced NSCLC: OS for stage I and preliminary stage II efficacy. J Clin Oncol. 2019;37(15).; http://hdl.handle.net/10541/622443; Journal of Clinical Oncology

  8. 8
  9. 9

    المصدر: ANNALS OF ONCOLOGY
    r-FISABIO. Repositorio Institucional de Producción Científica
    instname
    r-FISABIO: Repositorio Institucional de Producción Científica
    Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
    Annals of Oncology
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
    Academic Journal

    المساهمون: Soria, J, Tan, D, Chiari, R, Wu, Y, Paz-Ares, L, Wolf, J, Geater, S, Orlov, S, Cortinovis, D, Yu, C, Hochmair, M, Cortot, A, Tsai, C, Moro-Sibilot, D, Campelo, R, Mcculloch, T, Sen, P, Dugan, M, Pantano, S, Branle, F, Massacesi, C, de Castro, G

    وصف الملف: STAMPA

    Relation: info:eu-repo/semantics/altIdentifier/pmid/28126333; info:eu-repo/semantics/altIdentifier/wos/WOS:000395263400031; volume:389; issue:10072; firstpage:917; lastpage:929; numberofpages:13; journal:THE LANCET; https://hdl.handle.net/10281/450564; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85010189205

  17. 17
  18. 18
  19. 19
    Academic Journal

    المساهمون: Rolfo, C, Raez, Le, Russo, A, Reguart, N, Campelo, Rg, Bronte, G, Papadimitriou, K, Silvestris, Francesco

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000328109400004; volume:14; issue:1; firstpage:15; lastpage:26; numberofpages:12; journal:EXPERT OPINION ON BIOLOGICAL THERAPY; http://hdl.handle.net/11586/93201; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84890172631

  20. 20
    Electronic Resource